Retinitis Pigmentosa (RP) is the most prevalent degenerative retinal disease of mendelian origin, currently affecting approximately 1.5 million people worldwide. To date it has been established that a minimum of five different genes maybe involved in the pathogenesis of autosomal dominant forms of RP (adRP). The genes encoding two retinal specific proteins, rhodopsin and peripherin/RDS, have been implicated in causing adRP due to the observation of many different mutations in these genes in patients suffering from RP. The three remaining adRP genes have been mapped to specific regions of human chromosomes but as yet are uncharacterised. We have investigated if there is evidence for the presence of another locus in the genome which when mutated causes adRP. We have utilised polymorphic genetic markers which have previously been mapped to each of the regions known to harbour adRP genes, to test for the exclusion or linkage of the disease gene segregating in a pedigree of Irish origin and find no evidence for linkage. Hence we provide definitive evidence for the involvement of yet another locus. The implications of high levels of genetic heterogeneity inherent in adRP are discussed in relation to diagnosis, prognosis and future therapies.
INTRODUCTION
The exploitation of polymorphism intrinsic to the human genome has led to the development of many highly informative genetic markers, the newest generation of which are based on simple sequence repeats i.e. microsatellites. Such genetic markers have been applied successfully in the localisation of genes responsible for many inherited diseases, not least among these being a group of inherited eye disorders termed Retinitis Pigmentosa (RP).
RP is the name given to a complex array of retinopathies characterised by photoreceptor degeneration, visual field loss, night blindness, retinal pigment deposition, vessel attenuation and diminished or non-recordable electroretinograms. The presentation of the disease varies significantly between patients in severity, age of onset, progression and ophthalmic features (1) . The clinical variation is paralleled by genetic heterogeneity. RP can be inherited autosomal recessively (arRP), autosomal dominantly or in an X-linked fashion (xlRP). However, within each category based on pattern of inheritance there is further genetic heterogeneity.
The application of DNA technologies in the study of RP has led to the localisation and characterisation of a number of adRP genes. The first adRP locus was localised to the long arm of chromosome three (2), close to the gene encoding the photoreceptor protein rhodopsin (3) . Approximately sixty rhodopsin mutations have now been identified in adRP patients implicating mutant rhodopsin molecules in the pathogenesis of some forms of adRP and indicating the presence of allelic genetic heterogeneity in adRP (4). More recently, mutant forms of a second photoreceptor specific protein, peripherin/ RDS, have been implicated in adRP. Similar to the first linkage on chromosome 3, the localisation of an adRP locus on 6p, close to the gene encoding RDS, stimulated a search for mutations within this gene (5) . To date at least 12 mutations have been identified in the RDS gene in RP patients and in patients with related retinopathies (6) (7) (8) (9) (10) . Further linkage studies with adRP families of American and European origins have resulted in the localisation of three more genes. The first of these mapped to the pericentric region of chromosome 8 in a large American family (11) . Most recently, we have mapped two adRP loci on chromosome 7, one to the short arm close to the marker D7S460 (5=0.00, Z = 5.60) in an English family (12) and the other to the long arm close to D7S480 (6=0.00, Z=7.2) in a Spanish family (13) . In each case, no obvious candidate genes have been
To whom correspondence should be addressed mapped close to the regions of linkage. There has been some discussion as to the possible involvement of mutations in the R0M1 gene on chromosome 11 in adRP (14) . However, these data have still to be confirmed. Similarly there has been implications of a second adRP locus on 3q (15) . However, in the light of new data, there is now no substantial evidence for this hypothesis (16) . In this study, we have used highly informative microsatellite markers in each of the regions of the genome known to harbour adRP loci, that is, 3q, 6p, 7p, 7q and the pericentric region of Figure 2 . Exclusion of the adRP gene from a 65 cM region on chromosme 7q. The locus D7S530 was arbitrarily set at 0 cM and D7S514, D7S486 and D7S523 were set proximally at 3 cM, 9cM and 1 lcM respectively from it. Distances were fixed according to the Genome Data Base. chromosome 8 to investigate if there is further non allelic genetic heterogeneity in adRP.
RESULTS AND DISCUSSION
Recent localisation of the fourth and fifth adRP genes to chromosome 7p and 7q respectively has prompted us to address the question of further non allelic genetic heterogeneity in adRP, i.e., the possible existence of a sixth locus. To do this we have used thirty-four members of an Irish family (ZMK-92) which exhibits an early onset form of adRP in association with deafness. Variations in age of onset, severity and clinical presentation between family members have been well documented elsewhere (17) .
The disease gene segregating in ZMK-92 has been tested for linkage to all regions to which adRP genes have previously been mapped. In the case of the rhodopsin gene (3q) and the RDS gene (6p), the observation of recombination events with intragenic polymorphisms significantly excluded the involvement of these loci in the disease process (17) . The adRP gene localised to the pericentric region of chromosome 8 in a single large American adRP family has also previously been excluded in this adRP pedigree. The DNA markers closest to the 7p and 7q adRP linkages have been typed in all thirty-four members of ZMK-92 in our study and have resulted in the exclusion of the disease gene from close linkage to each marker locus ( Table 1 ). The data from multiple genetic markers in both chromosomal regions was incorporated into multipoint analyses to extend the respective areas excluded. For example, we excluded the disease gene from a genetic distance of approximately 40cM around the 7p adRP linkage, centered at the marker D7S435 (Fig. 1) . Similarly, the adRP gene in ZMK-92 has been excluded from approximately 65cM around the 7q adRP linkage, centered around the marker D7S530 (Fig. 2) .
Family ZMK-92 has also been typed with DNA markers which are closely linked to the R0M1 gene on chromosome 1 lq (Table  1) which may be involved in adRP (14) , although as yet no definitive evidence of this has been published . Similarly, using a polymorphism approximately 25 Kb from the gene encoding the /3-subunit of cGMP Phosphodiesterase (/3-PDE) on chromosome 4p, we have investigated the possible involvement of this gene in the disease observed in ZMK-92. A mutant form of /3-PDE has previously been shown to be involved in the retinopathy of the rd mouse (18) and more recently in arRP (19) . Again, significant exclusion was obtained in both cases indicating that the retinopathy present in this family is not as a result of mutations in either of these candidate genes.
In conclusion, we have excluded the involvement of all known adRP loci in ZMK-92, a family presenting with adRP and deafness. Hence we have firmly established the existence of yet another locus, a sixth locus, which when mutated leads to an autosomal dominantly inherited RP retinopathy. Such high levels of heterogeneity creates enormous difficulties for accurate diagnosis, prognosis and future treatment. In many cases an individual family will not be large enough to test if the disease gene is linked to any of the 5 regions of the genome to which adRP genes have been mapped. Moreover, the family may represent a previously unlocalised gene, as is clearly exemplified in this paper. If, for example, it is possible to establish that the disease gene maps close to rhodopsin, then a second level of genetic heterogeneity is encountered. Many of the rhodopsin mutations identified in 3q linked adRP families are family specific, that is, to date they have only been observed in a single family (20, 21) . Therefore diagnosis at the molecular level may involve the identification of a novel mutation and hence may prove impractical for genetic services with budgetary restrictions. However, an initial step towards accurate diagnosis must be the localisation and characterisation of all disease causing genes. Hence, studies such as this one will play an important role in moving towards this end. Furthermore, one inevitable benefit of the genetic heterogeneity present in RP will be the characterisation of biologically important retinal specific genes and hence an increase in our understanding of the functioning of the healthy retina.
MATERIALS AND METHODS
ZMK-92 is an Irish pedigree in which RP segregates in an autosomal dominant fashion and has been described previously (17) . The segregation ratio for ZMK-92 did not differ significantly from that expected under the hypothesis of full penetrance of an autosomal dominant gene, i.e a segregation ratio of 0.5 (or 50%). Affected individuals initially present with hearing difficulties in their teens. In their twenties patients notice symptoms referable to night vision impairment and peripheral visual field loss. Young affected individuals show abnormal electroretinographic responses before the onset of symptoms. Individuals in the fifth and sixth decades have no detectable rod or cone responses.
Individuals were typed for microsatellite markers on chromosomes 7p and 7q (Table 1) . PCR was carried out in a 20>il volume containing 200ng of genomic DNA, 200/JM of dATP, dTTP, dGTP and 2.5/JM dCTP, 1/iCi aP 3 2 dCTP, 50mM KC1, lOmM Tris-HCl (pH8.3), 1.5mM MgCl 2 , 0.01% gelatin (w/v), 0.1% Triton X-100, 20pmol of each primer and 0.75 units Taq polymerase. Samples were denatured at 94°C for 4 min prior to the addition of the7a<j polymerase and processed through 32 cycles of 30 sec at 94°C, 30s at 55°C and 40s at 72°C. Aliquots of the amplified DNA were mixed with an equal volume of formamide buffer and electrophoresed on 8% denaturing polyacrylamide gels.
Mapping data were compiled with the data management package LINKSYS (22) Version 4.11 and calculations performed with LIPED (23) and the LINKA-GE (24) Version 4.9 package of programmes on a VAX 6230 and a 640K PC. Male and female recombination rates were taken to be equal and full penetrance of the autosomal gene was assumed in the analyses. A gene frequency of 0.001 was assumed for the disease locus and the Kosambi mapping function was used to convert recombination fraction to map distance in all analyses.
